Found: 144
Select item for more details and to access through your institution.
Hepatocellular carcinoma, vascular endothelial growth factor receptors‐targeting agents, and hypertension: A much more complicated relationship than expected.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 8, p. 1208, doi. 10.1002/cncr.35218
- By:
- Publication type:
- Article
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1223282
- By:
- Publication type:
- Article
Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1343027
- By:
- Publication type:
- Article
Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 254, doi. 10.1093/oncolo/oyad348
- By:
- Publication type:
- Article
Assessment of bone turnover markers and DXA parameters to predict bone metastasis progression during zoledronate treatment: a single-center experience.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-023-01280-1
- By:
- Publication type:
- Article
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 483, n. 6, p. 821, doi. 10.1007/s00428-023-03688-2
- By:
- Publication type:
- Article
Mucosal Melanoma: Epidemiology, Clinical Features, and Treatment.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 11, p. 1247, doi. 10.1007/s11912-023-01453-x
- By:
- Publication type:
- Article
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1223282
- By:
- Publication type:
- Article
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
- Published in:
- Minerva Urology & Nephrology, 2023, v. 75, n. 4, p. 460, doi. 10.23736/S2724-6051.23.05369-7
- By:
- Publication type:
- Article
STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 483, n. 1, p. 87, doi. 10.1007/s00428-023-03549-y
- By:
- Publication type:
- Article
The emerging role of PI3K inhibitors for solid tumour treatment and beyond.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 12, p. 2150, doi. 10.1038/s41416-023-02221-1
- By:
- Publication type:
- Article
Adamantinoma-like Ewing sarcoma of the salivary glands: a case report and systematic literature review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231165979
- By:
- Publication type:
- Article
Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1542, doi. 10.3390/cancers15051542
- By:
- Publication type:
- Article
Tivozanib in Patients with Advanced Renal Cell Carcinoma Previously Treated with Axitinib: Subgroup Analysis from TIVO-3.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. e167, doi. 10.1093/oncolo/oyac255
- By:
- Publication type:
- Article
Artificial intelligence-based prediction of overall survival in metastatic renal cell carcinoma.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1021684
- By:
- Publication type:
- Article
Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 1, p. 72, doi. 10.1093/oncolo/oyac186
- By:
- Publication type:
- Article
Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology.
- Published in:
- Journal of Translational Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12967-022-03744-6
- By:
- Publication type:
- Article
Randomized Phase II Trial of Sapanisertib ± TAK-117 vs. Everolimus in Patients With Advanced Renal Cell Carcinoma After VEGF-Targeted Therapy.
- Published in:
- Oncologist, 2022, v. 27, n. 12, p. 1048, doi. 10.1093/oncolo/oyac192
- By:
- Publication type:
- Article
Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy?
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 389, doi. 10.1007/s11060-022-04155-9
- By:
- Publication type:
- Article
IL-8 and its role as a potential biomarker of resistance to antiangiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.990568
- By:
- Publication type:
- Article
Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.957068
- By:
- Publication type:
- Article
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cabozantinib combination therapy for the treatment of solid tumors: a systematic review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221108691
- By:
- Publication type:
- Article
Cabozantinib for the treatment of solid tumors: a systematic review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221107112
- By:
- Publication type:
- Article
Circulating tumor cells from melanoma patients show phenotypic plasticity and metastatic potential in xenograft NOD.CB17 mice.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Temporal Trends in Grade 3/4 Adverse Events and Associated Costs of Nivolumab Plus Cabozantinib Versus Sunitinib for Previously Untreated Advanced Renal Cell Carcinoma.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 7, p. 611, doi. 10.1007/s40261-022-01170-6
- By:
- Publication type:
- Article
Redistribution of CD8+ T cell subsets in metastatic renal cell carcinoma patients treated with anti‐PD‐1 therapy.
- Published in:
- Cytometry. Part A, 2022, v. 101, n. 7, p. 597, doi. 10.1002/cyto.a.24562
- By:
- Publication type:
- Article
Molecular Aberrations Stratify Grade 2 Astrocytomas Into Several Rare Entities: Prognostic and Therapeutic Implications.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.866623
- By:
- Publication type:
- Article
Conditional survival and long‐term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 11, p. 2085, doi. 10.1002/cncr.34180
- By:
- Publication type:
- Article
SIRM-SIN-AIOM: appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations—consensus statements from Italian College of Radiology (SIRM), Italian College of Nephrology (SIN) and Italian Association of Medical Oncology (AIOM)
- Published in:
- La Radiologia Medica, 2022, v. 127, n. 5, p. 534, doi. 10.1007/s11547-022-01483-8
- By:
- Publication type:
- Article
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 8, p. 4173, doi. 10.3390/ijms23084173
- By:
- Publication type:
- Article
Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 3826, doi. 10.3390/ijms23073826
- By:
- Publication type:
- Article
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221079580
- By:
- Publication type:
- Article
Correlation between targeted RNAseq signature of breast cancer CTCs and onset of bone-only metastases.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 3, p. 419, doi. 10.1038/s41416-021-01481-z
- By:
- Publication type:
- Article
Correlation between targeted RNAseq signature of breast cancer CTCs and onset of bone-only metastases.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 1, p. 17, doi. 10.3390/cells11010017
- By:
- Publication type:
- Article
A Glimpse in the Future of Malignant Mesothelioma Treatment.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.809337
- By:
- Publication type:
- Article
Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16).
- Published in:
- Oncology, 2021, v. 99, n. 12, p. 747, doi. 10.1159/000515951
- By:
- Publication type:
- Article
Biological Therapeutic Advances for the Treatment of Advanced Urothelial Cancers.
- Published in:
- Biologics: Targets & Therapy, 2021, v. 15, p. 441, doi. 10.2147/BTT.S290311
- By:
- Publication type:
- Article
Playing the Devil's Advocate: Should We Give a Second Chance to mTOR Inhibition in Renal Clear Cell Carcinoma? – ie Strategies to Revert Resistance to mTOR Inhibitors.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 7623, doi. 10.2147/CMAR.S267220
- By:
- Publication type:
- Article
The psychological impact of COVID‐19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability.
- Published in:
- Journal of Neuroendocrinology, 2021, v. 33, n. 10, p. 1, doi. 10.1111/jne.13041
- By:
- Publication type:
- Article
Liquid Biopsy in Cervical Cancer: Hopes and Pitfalls.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 3968, doi. 10.3390/cancers13163968
- By:
- Publication type:
- Article
Primary Soft Tissue Sarcoma of the Heart: An Emerging Chapter in Cardio-Oncology.
- Published in:
- Biomedicines, 2021, v. 9, n. 7, p. 774, doi. 10.3390/biomedicines9070774
- By:
- Publication type:
- Article
Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 13, p. 6813, doi. 10.3390/ijms22136813
- By:
- Publication type:
- Article
Impact of SARS-CoV-2 Pandemic on Kidney Cancer Management.
- Published in:
- Kidney Cancer (2468-4562), 2021, v. 5, n. 2, p. 93, doi. 10.3233/KCA-210112
- By:
- Publication type:
- Article
Donafenib in Chinese patients with advanced hepatocellular carcinoma (HCC): Really a new standard of care, or should we change paradigm for drug development in HCC?
- Published in:
- Oncology Reviews, 2021, v. 15, n. 2, p. 36, doi. 10.4081/oncol.2021.564
- By:
- Publication type:
- Article
Hepatic Arterial Infusion of Chemotherapy for Advanced Hepatobiliary Cancers: State of the Art.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 3091, doi. 10.3390/cancers13123091
- By:
- Publication type:
- Article
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1667, doi. 10.1007/s00262-020-02810-6
- By:
- Publication type:
- Article
Prognostic Factors and Current Treatment Strategies for Renal Cell Carcinoma Metastatic to the Brain: An Overview.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2114, doi. 10.3390/cancers13092114
- By:
- Publication type:
- Article
The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice.
- Published in:
- Genes, 2021, v. 12, n. 5, p. 727, doi. 10.3390/genes12050727
- By:
- Publication type:
- Article